Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.70p
   
  • Change Today:
    -0.20p
  • 52 Week High: 17.60
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 2,470,586
  • Market Cap: £33.68m
  • RiskGrade: 328
  • Beta: 1.23

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £99,727
Lisa Baderoon 583,963 £39,126
Tim Franklin 525,000 £35,175

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £1,682,239
Invesco Ltd 17,872,341 £1,197,447
Aviva Investors Global 11,285,180 £756,107
Alora Pharmaceuticals LLC 10,909,091 £730,909
M&G Investments 7,600,000 £509,200
Prudential plc 7,600,000 £509,200
Capital Income Builder 4,870,367 £326,315
Dr R Zimmer 4,551,553 £304,954
Odey Asset Management 3,433,319 £230,032
Rhone Trustees (Switzerland) SA 3,386,000 £226,862
Pictet Overseas Trust Corporation Limited 3,287,500 £220,262

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 6.70p
Change Today -0.20p
% Change -2.90 %
52 Week High 17.60
52 Week Low 1.50
Volume 2,470,586
Shares Issued 502.72m
Market Cap £33.68m
Beta 1.23
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 21-Jan-2026

Time Volume / Share Price
15:51 104,351 @ 6.70p
16:35 3,405 @ 6.70p
16:35 3,398 @ 6.70p
16:35 7 @ 6.70p
16:29 1,482 @ 6.42p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page